KR970705578A - 신규의 면역피임 펩티드류(new immunocontraceptive peptides) - Google Patents
신규의 면역피임 펩티드류(new immunocontraceptive peptides)Info
- Publication number
- KR970705578A KR970705578A KR1019970701103A KR19970701103A KR970705578A KR 970705578 A KR970705578 A KR 970705578A KR 1019970701103 A KR1019970701103 A KR 1019970701103A KR 19970701103 A KR19970701103 A KR 19970701103A KR 970705578 A KR970705578 A KR 970705578A
- Authority
- KR
- South Korea
- Prior art keywords
- antibody
- peptide
- amino acid
- acid sequence
- seq
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract 23
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract 4
- 230000002796 immunocontraceptive effect Effects 0.000 title 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 10
- 125000000539 amino acid group Chemical group 0.000 claims abstract 2
- 230000001363 autoimmune Effects 0.000 claims abstract 2
- 229960005486 vaccine Drugs 0.000 claims abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 3
- 210000004408 hybridoma Anatomy 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940039227 diagnostic agent Drugs 0.000 claims 1
- 239000000032 diagnostic agent Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 230000009870 specific binding Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 241000985610 Forpus Species 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94202392.0 | 1994-08-22 | ||
| EP94202392 | 1994-08-22 | ||
| PCT/EP1995/003311 WO1996006113A1 (en) | 1994-08-22 | 1995-08-18 | New immunocontraceptive peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR970705578A true KR970705578A (ko) | 1997-10-09 |
Family
ID=8217113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019970701103A KR970705578A (ko) | 1994-08-22 | 1995-08-18 | 신규의 면역피임 펩티드류(new immunocontraceptive peptides) |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0777688A1 (fi) |
| JP (1) | JPH10505340A (fi) |
| KR (1) | KR970705578A (fi) |
| CN (1) | CN1158623A (fi) |
| AU (1) | AU3471395A (fi) |
| BR (1) | BR9508748A (fi) |
| CA (1) | CA2198265A1 (fi) |
| FI (1) | FI970744A0 (fi) |
| HU (1) | HUT77262A (fi) |
| WO (1) | WO1996006113A1 (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19622289A1 (de) * | 1996-05-23 | 1997-11-27 | Schering Ag | Zona Pellucida Proteine zur Kontrazeption |
| AU3594397A (en) * | 1996-07-03 | 1998-01-21 | Zygam, Inc. | Immunocontraceptive compositions containing sperm antigens, and methods of use |
| CN1291229A (zh) | 1998-02-19 | 2001-04-11 | 东弗吉尼亚医学院 | 重组的活性人透明带蛋白3 |
| US7037663B2 (en) | 1998-02-19 | 2006-05-02 | Eastern Virginia Medical School | Human zona pellucida protein 3 and uses thereof |
| CA2456821A1 (en) | 2001-08-02 | 2003-02-13 | Trinity Biomedical Technology Corporation | Human zona pellucida proteins and methods of their use in diagnosing male infertility |
| CN101906163B (zh) * | 2009-06-05 | 2012-06-27 | 上海交通大学医学院 | 一种免疫避孕的合成肽和嵌合肽及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4996297A (en) * | 1987-10-07 | 1991-02-26 | Zonagen, Inc. | Recombinantly expressed rabbit zona pellucida polypeptides |
| JPH05500654A (ja) * | 1989-06-12 | 1993-02-12 | アメリカ合衆国 | クローン化透明帯遺伝子を基本とする避妊ワクチン |
| IE912872A1 (en) * | 1990-08-27 | 1992-03-11 | Akzo Nv | Human zona pellucida protein zp3 |
| JPH05176771A (ja) * | 1991-11-29 | 1993-07-20 | Tonen Corp | ブタ卵透明帯ｐｚｐ−３をコードするｄｎａ |
| JPH0614784A (ja) * | 1991-11-29 | 1994-01-25 | Tonen Corp | ネコ卵透明帯ｆｚｐ−３をコードするｄｎａ、その発現ペプチド、および該ペプチド含有避妊ワクチン |
| JPH05336974A (ja) * | 1991-12-26 | 1993-12-21 | Tonen Corp | イヌ卵透明帯ｃｚｐ−３をコードするｄｎａ、該ｄｎａによってコードされるｃｚｐ−３関連ペプチド、および該ペプチド含有避妊ワクチン |
| JPH06179698A (ja) * | 1992-12-15 | 1994-06-28 | Tonen Corp | ブタ卵透明帯ｐｚｐ−３関連ペプチド |
| JPH06217777A (ja) * | 1993-01-29 | 1994-08-09 | Tonen Corp | ネコ卵透明帯ｆｚｐ２をコードするｄｎａ配列 |
-
1995
- 1995-08-18 AU AU34713/95A patent/AU3471395A/en not_active Abandoned
- 1995-08-18 CA CA002198265A patent/CA2198265A1/en not_active Abandoned
- 1995-08-18 CN CN95195212.9A patent/CN1158623A/zh active Pending
- 1995-08-18 HU HU9701726A patent/HUT77262A/hu unknown
- 1995-08-18 EP EP95931169A patent/EP0777688A1/en not_active Ceased
- 1995-08-18 JP JP8507795A patent/JPH10505340A/ja active Pending
- 1995-08-18 KR KR1019970701103A patent/KR970705578A/ko not_active Application Discontinuation
- 1995-08-18 WO PCT/EP1995/003311 patent/WO1996006113A1/en not_active Application Discontinuation
- 1995-08-18 BR BR9508748A patent/BR9508748A/pt not_active Application Discontinuation
-
1997
- 1997-02-21 FI FI970744A patent/FI970744A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI970744A (fi) | 1997-02-21 |
| FI970744A0 (fi) | 1997-02-21 |
| BR9508748A (pt) | 1997-08-12 |
| CA2198265A1 (en) | 1996-02-29 |
| EP0777688A1 (en) | 1997-06-11 |
| HUT77262A (hu) | 1998-03-02 |
| WO1996006113A1 (en) | 1996-02-29 |
| MX9701304A (es) | 1998-05-31 |
| JPH10505340A (ja) | 1998-05-26 |
| AU3471395A (en) | 1996-03-14 |
| CN1158623A (zh) | 1997-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6641813B1 (en) | Methods and reagents for diagnosis of autoantibodies | |
| CA2251464A1 (en) | Non-dendritic backbone peptide carrier | |
| KR910016343A (ko) | 사람 파필로마바이러스(hpv) 16 단백질의 혈청반응성 에피토프 | |
| DE3855479T2 (de) | Hiv-peptide, künstliche hiv-antigene und immuntestsätze | |
| BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
| CA2391356A1 (en) | Peptides designed for the diagnosis and treatment of rheumatoid arthritis | |
| Marchalonis et al. | Natural human antibodies to synthetic peptide autoantigens: correlations with age and autoimmune disease | |
| KR970705578A (ko) | 신규의 면역피임 펩티드류(new immunocontraceptive peptides) | |
| CA2117904C (en) | Methods and reagents for diagnosis of autoantibodies | |
| Fahrenkrug et al. | Production and evaluation of antibodies for radioimmunoassay of secretin | |
| JO1671B1 (en) | New ways to diagnose tuberculosis | |
| WO1997018475A1 (en) | Compounds and methods for the detection and prevention of t. cruzi infection | |
| KR930703444A (ko) | 어류 황체화 호르몬-방출 호르몬 동족체 | |
| RU2001127439A (ru) | Пептиды из последовательности Т-вируса и моноспецифические антитела, связывающиеся с ТТ-вирусом | |
| Ekramoddoullah et al. | Partial characterization of an antigenic site of high molecular weight basic antigen, a ryegrass pollen allergen, using a monoclonal antibody | |
| Fritz et al. | Specificity of antisera from Lewis rats immunized with encephalitogenic fragment 43–88 of guinea pig myelin basic protein | |
| EP0595638B1 (en) | Epitope-related peptides of human parvovirus | |
| WO1992018528A1 (en) | Branched peptides in assays for antibodies | |
| EP0470205A1 (en) | New human parvovirus peptides with disulfide bridge for immunization or diagnosis | |
| GB2299994A (en) | Equine arteritis virus peptides antibodies and their use in a diagnostic test | |
| KR910007962A (ko) | Hiv 관련 펩티드 | |
| Fischer et al. | Synthetic peptide antigens of tetanus toxin | |
| JPH06293798A (ja) | ヒトパルボウイルスｂ１９のエピトープ関連ペプチド | |
| Davies et al. | Mimicry between HTLV-I and myelin basic protein: no response in HTLV-I-associated myelopathy patients | |
| Ito et al. | A key amino acid determining G3m (b) allotypic markers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |